Agilon Health Q2 Sales $1.483B Miss $1.560B Estimate
Portfolio Pulse from Benzinga Newsdesk
Agilon Health (NYSE:AGL) reported Q2 sales of $1.483 billion, missing the analyst consensus estimate of $1.560 billion by 4.91%. Despite the miss, sales increased by 29.07% compared to the same period last year.
August 06, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Agilon Health reported Q2 sales of $1.483 billion, missing the analyst consensus estimate of $1.560 billion by 4.91%. However, sales increased by 29.07% compared to the same period last year.
The miss on sales estimates is likely to have a negative short-term impact on Agilon Health's stock price. However, the significant year-over-year sales growth may mitigate some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100